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HTLV-1 and HTLV-2 share broad similarities in their overall genetic organization and
expression pattern, but they differ substantially in their pathogenic properties. This review
outlines distinctive features of HTLV-1 and HTLV-2 that might provide clues to explain their
distinct clinical outcomes. Differences in the kinetics of viral mRNA expression, functional
properties of the regulatory and accessory proteins, and interactions with cellular factors
and signal transduction pathways are discussed.
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INTRODUCTION
Four types of HTLV have been described so far, the most prevalent
types being HTLV-1 and HTLV-2 (Gessain et al., 2013).
HTLV-1 and HTLV-2 show considerable homology in terms
of genome structure, replication pattern, and properties of the
structural, regulatory, and accessory proteins. Their transmis-
sion follows the same route, by transfer of infected lymphocytes
by perinatal transmission and breastfeeding and through blood
transfusion, sexual contact, and use of intravenous drugs (Pique
and Jones, 2012). Both viruses utilize the GLUT-1 and NRP1
cellular receptors for their entry, although HTLV-1, but not
HTLV-2, is dependent on heparan sulfate proteoglycans (Jones
et al., 2006). Cell-to-cell transmission is essential for virus repli-
cation and occurs through the formation of a virological synapse
(Nejmeddine et al., 2005).
Despite these important analogies, HTLV-1 and HTLV-2 are
strikingly different in terms of clinical impact, as only HTLV-1
is conclusively associated with neoplasia, namely adult T-cell
leukemia/lymphoma (ATLL), which develops in up to 5% of
infected individuals. A similar percentage of HTLV-1-infected
persons develop a neurological disease termed HTLV-associated
myeolopathy/tropical spastic paraparesis (HAM/TSP; Gessain and
Mahieux, 2012). In contrast, HTLV-2, though persistently asso-
ciated with elevated lymphocyte and platelet counts (Bartman
et al., 2008) and with an increase in overall cancer mortality
(Biswas et al., 2010), does not cause hematologic disorders and
is only sporadically associated with myelopathy (Araujo and Hall,
2004).
The two viruses also differ in their geographical distribution.
HTLV-1 is endemic in Japan, sub-Saharan Africa, South America,
and the Caribbean (Gessain and Cassar, 2012), whereas HTLV-2 is
prevalent among the indigenous populations in Africa and the
Indian-American tribes in Central and South America as well
as among drug users in Europe and North America (Zella et al.,
1990; Roucoux and Murphy, 2004). Although their receptor usage
allows HTLV-1 and HTLV-2 to be quite promiscuous for different
cell types in vitro, they exhibit distinct cellular tropisms in vivo:
HTLV-1 is mainly found in CD4+ T lymphocytes, whereas CD8+
T cells are the preferred target for HTLV-2 (Ijichi et al., 1992).
The following sections highlight differences in the biology of
HTLV-1 and HTLV-2 that might provide clues to their distinct
clinical outcomes. Emphasis is placed on the comparison of the
regulatory proteins, kinetics of mRNA expression, clonal distri-
bution patterns, and interaction with cellular factors and signal
transduction pathways.
THE COMPARATIVE ANATOMY OF THE HTLV-1 AND HTLV-2
GENOMES
In their pioneering studies, Seiki et al. (1983) noted the pres-
ence of a region in the HTLV-1 genome between the env open
reading frame (ORF) and the 3′ LTR that was not present in
the previously described oncogenic retroviruses. This region,
termed the “X region,” is also present in HTLV-2 and codes
for the regulatory and accessory proteins in partially overlap-
ping ORFs named x-I through x-V. Expression of the complex
arrangement of ORFs in such a compact genome is accomplished
by a combination of ribosomal frameshifting, alternative splic-
ing, and polycistronic translation (Ciminale et al., 1992, 1995;
Koralnik et al., 1992) aswell as production of negative-strand tran-
scripts that code for the HBZ (HTLV-1) and APH-2 (HTLV-2)
proteins.
Like other retroviruses, the HTLVs produce an unspliced
mRNA which codes for the Gag-Pol-Pro precursor protein and
also serves as the viral genome and a singly spliced mRNA that
codes for the Env surface glycoproteins. Peculiar to the HTLVs is
the expression of the Tax and Rex regulatory proteins that play
critical roles in driving expression from the 5′ LTR promoter (Tax)
and in enhancing the expression of partially spliced plus-strand
mRNAs (Rex). TheTax andRexORFs (x-IV andx-III, respectively)
are expressed from the same doubly spliced mRNA. In HTLV-1,
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all the other X region proteins are coded by individual singly or
doubly spliced transcripts, while some HTLV-2 transcripts express
more than one ORF.
Recent studies of the temporal sequence of HTLV-1 gene
expression in peripheral blood mononuclear cells (PBMCs) iso-
lated from infected patients (Corradin et al., 2011; Rende et al.,
2011) revealed a “two-phase” kinetics with tax/rex mRNA expres-
sion preceding that of other viral transcripts. A similar analysis
of HTLV-2 mRNA expression indicated a comparable pattern,
although the relative abundance of some transcripts showed some
intriguing differences among the two viruses (Bender et al., 2012;
Cavallari et al., 2013).
Themajordifferences betweenHTLV-1 andHTLV-2geneprod-
ucts are summarized in Table 1 and commented in the following
sections.
Tax PROTEINS AND THEIR INTERACTIONS WITH CELLULAR
PATHWAYS
The principal role of Tax during viral replication is to activate
transcription of the LTR promoter through a process that involves
the recruitment of CREB/ATF complexes on binding sites in the
U3 region. Tax-1 and Tax-2 share this mechanism and are able to
cross-activate each others’ LTRs (Semmes et al., 1996).
Experiments performed in the early 1990s established a key
role for Tax as the main viral oncoprotein necessary for the initial
steps of T-cell transformation by HTLV-1 (Tanaka et al., 1990).
Transgenic mouse models have consistently demonstrated that
Tax expression causes tumors, including lymphoma and leukemia
(Ruddle et al., 1993; Hasegawa et al., 2006). Recent comparative
studies on the transforming activities of HTLV-1 Tax (Tax-1)
and HTLV-2 Tax (Tax-2) demonstrated that, in the absence of
other viral proteins, both Tax-1 and Tax-2 immortalize human
primary CD4+ T cells, but only Tax-2 is able to immortalize
CD8+ T cells (Imai et al., 2013). Furthermore, Tax-2 immortal-
izes human primary CD4+ T cells more efﬁciently than Tax-1
(Imai et al., 2013). Although additional viral products have been
demonstrated to be relevant for immortalization, the interactions
between Tax and host proteins are still considered to be essential
for the transformation process. Several studies of the oncogenic
properties of Tax-1 highlighted its effects on DNA repair, cell
cycle progression, cell death, and p53 function (reviewed by
Cheng et al., 2012).
In addition to CREB/ATF proteins, Tax-1 interacts with many
other host factors that inﬂuence cell proliferation and transfor-
mation, including components of the PI3K, AKT, MAPK, TGFβ,
SRF, and NF-κB pathways (Romanelli et al., 2013). Tax-2 has
been analyzed mainly for its effects on the NF-κB pathway, and
was shown to activate the canonical pathway, but, unlike Tax-1,
does not activate the noncanonical pathway (Shoji et al., 2009),
suggesting that activation of this latter pathway might be a key ele-
ment in HTLV-1-driven transformation in vivo. Although overall
highly homologous, Tax-1 and Tax-2 present some distinct struc-
tural features. Tax-1 contains a PDZ binding motif (PBM) and
leucine zipper domains that are absent in Tax-2. The C-terminal
PBM domain is relevant for interaction of Tax-1 with host fac-
tors that regulate cell cycle progression and proliferation, such
as the human homologue of the Drosophila melanogaster disk
large tumor suppressor protein (hDLG; Suzuki et al., 1999). The
leucine zipper regions present in the central region of Tax-1 are
responsible for activation of the non-canonical NF-κB pathway
(Higuchi and Fujii, 2009). The nuclear localization and nuclear
export signals of Tax-1 and Tax-2 present signiﬁcant differences
which could explain the predominant nuclear localization of
Tax-1 compared to Tax-2 (Turci et al., 2006, 2009; Avesani et al.,
2010).
An additional difference betweenTax-1 andTax-2 thatmay play
a role in NF-κB activation is the absence of interactions between
Tax-2 and TNF receptor-associated factor TRAF6, an E3 ubiq-
uitin ligase that is involved in ubiquitination of effectors of the
NF-κB pathway (Journo et al., 2013). Both Tax-1 and Tax-2 are
ubiquitinated and SUMOylated, but they differ in the pattern of
modiﬁcation (Zane and Jeang, 2012). The role of ubiquitination,
sumoylation, and acetylation of Tax in NF-κB activation and cel-
lular transformation is still an open ﬁeld of research (Turci et al.,
2012; Xiao, 2012; Journo et al., 2013; Lodewick et al., 2013).
Activationof NF-κBbyTax is also connected to thederegulation
of autophagy, an additional pathway that is altered in oncogenic
signaling. Both Tax-1 and Tax-2 induce autophagosome accumu-
lation, but their interactions with the components of the process
differ. In fact, Tax-1 (but not Tax-2) directs the IKK complex to
lipid rafts associated with autophagic molecules such as Beclin 1
and Bif-1 (Huang et al., 2009; Ren et al., 2013).
POST-TRANSCRIPTIONAL REGULATION BY Rex
HTLV-1 Rex (Rex-1) and HTLV-2 Rex (Rex-2) share 60% homol-
ogy at the amino acid level. Rex-1 and Rex-2 are phosphorylated
proteins that actively shuttle between the nucleus and the cyto-
plasm (Palmeri and Malim, 1996; Narayan et al., 2003) and
accumulate in the nucleus and nucleoli (Nosaka et al., 1989;
Ciminale et al., 1995, 1997; Nosaka et al., 1995; Narayan et al.,
2003), a property that is intimately linked to their ability to
enhance the nuclear export of incompletely spliced viral mRNAs.
Rex-1 and Rex-2 share a similar domain structure which
includes: (i) a nuclear localization signal (NLS; Siomi et al.,
1988; Nosaka et al., 1989), which mediates binding to the RXRE
(Grassmann et al., 1991) located at the 3′ end of all HTLV-1 tran-
scripts and at the 5′ end of the unspliced HTLV-2 mRNA (Ohta
et al., 1988; Black et al., 1991); (ii) multimerization domains; and
(iii) a leucine-rich sequence located near the middle of the pro-
tein (Rex-1 aa 79–99; Rex-2 aa 81–94), which functions as an
activation domain (AD; Weichselbraun et al., 1992) and contains
the nuclear export signal (NES; Kim et al., 1996; Palmeri and
Malim, 1996) that interacts with CRM1/exportin, which medi-
ates the nuclear export of the Rex-viral mRNA complex (Bogerd
et al., 1995; Kim et al., 1996; Palmeri and Malim, 1996). In addi-
tion a C-terminal domain unique to Rex-2 is a target for serine
phosphorylation and may also contribute to efﬁcient nucleo-
cytoplasmic shuttling (Narayan et al., 2003). Although Rex is not
required for cellular immortalization in vitro, it is necessary for
infectivity and viral persistence in vivo (Ye et al., 2003), as it is
required for the expression of the virion-associated structural
proteins.
The dependence of HTLV mRNAs on Rex function is con-
trolled by positively and negatively acting RNA sequences present
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Table 1 | Structural and functional differences between HTLV-1 and HTLV-2 gene products.
Structural and functional properties Viral proteins Reference
HTLV-1 HTLV-2
Tax-1 Tax-2
LZR (leucine zipper domain) + − Higuchi and Fujii (2009)
p100 binding + − Shoji et al. (2009)
PDZ domain + − Suzuki et al. (1999)
CD4 + immortalization + ++ Imai et al. (2013)
p21Rex tRex
Inihibition of full-length Rex − + Ciminale et al. (1997)
Bai et al. (2012)
p30Tof p28
Interaction with the co-activator CBP/p300 + − Zhang et al. (2001)
p13 −
Increases mitochondrial K+ permeability and ROS
production; inhibits Tax function in the nucleus
+ − D’Agostino et al. (2005)
Silic-Benussi et al. (2009)
Andresen et al. (2011)
Silic-Benussi et al. (2010b)
p12 p10
Binding MHC-I heavy chains + + Johnson et al. (2000)
Binding to the IL-2R, calreticulin and calnexin and NFAT
activation
+ − Mulloy et al. (1996)
Ding et al. (2001)
Ding et al. (2002)
Albrecht et al. (2002)
p8 −
IncreasesT-cell contacts and intercellular conduits + − Van Prooyen et al. (2010b)
− p11 Ciminale et al. (1995)
Antisense viral proteins
HBZ APH-2
Inhibition of Tax-mediated transcription +++ + Halin et al. (2009)
p300/CBP interaction + − Clerc et al. (2008)
Transcriptional activity of c-Jun family − + Marban et al. (2012)
Induction of cell proliferation + − Douceron et al. (2012)
Binding to Tax − + Hivin et al. (2005)
bZIP domain + − Marban et al. (2012)
on the primary transcript. Twomajor types of suchRNA cis-acting
elements have been described: (i) the Rex responsive element
(RXRE) which, besides binding Rex, acts as an inhibitory sequence
in the absence of Rex, and (ii) cis-acting repressive sequences
(CRS) that determine poor stability and/or inefﬁcient nucleo-
cytoplasmic export. HTLV-1 contains a CRS which maps at the
5′ end of the unspliced mRNA but is spliced out of the other
transcripts (Seiki et al., 1990; King et al., 1998). An additional
CRS overlaps the RXRE and acts synergistically with the 5′-
CRS. In contrast to the 5′-CRS, this 3′-CRS/RXRE is present
at the 3′ end of all viral transcripts. Both the 5′- and 3′-CRSs
were shown to act mainly as nuclear retention sequences. The
5′-CRS does not bind Rex-1 (Ballaun et al., 1991; Bogerd et al.,
1991; Unge et al., 1991), and its inhibitory function is likely to
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be mediated by other viral and/or cellular RNA-binding pro-
teins. Other cis-acting inhibitory elements (CIEs) were mapped
within the gag-pol and env regions of HTLV-1 (Saiga et al., 1997).
The inhibitory effect of these regions is counteracted by bind-
ing of Rex-1 to the RXRE, although it is not clear whether
they function mainly at the level of RNA stability or nucleo-
cytoplasmic export. A 5′-CRS acting as a nuclear retention
sequence was also mapped in the R-U5 region of HTLV-2 (Black
et al., 1991).
THE ACCESSORY PROTEINS
The “accessory” proteins were labeled as such because their abla-
tion does not have apparent consequences on viral replication
in vitro. However, studies performed in animal models indicate
that some of these proteins are essential for efﬁcient infectivity
in vivo. Among the accessory proteins, p30Tof/p28, p12/p10, and
p21Rex/tRex (in HTLV-1 and HTLV-2, respectively) are consid-
ered to be homologous based on their structure and functional
properties, while p13 and p8 appear to be unique to HTLV-1, and
p11 is peculiar to HTLV-2.
p21Rex and tRex are truncated forms of Rex-1 and Rex-2,
respectively, which lack the N-terminal arginine-rich NLS and
are therefore incapable of binding the RXRE. HTLV-2 tRex is
detected as four main isoforms of 22, 20, 18, and 17 kDa which
differ in the initiation codon usage and phosphorylation status
(Ciminale et al., 1997). The tRex proteins were shown to inhibit
Rex-2 function (Ciminale et al., 1997), an activity that might favor
latent infection. Although one study indicated that p21rex acts as
a repressor of full-length Rex (Heger et al., 1999), this ﬁnding was
not supported by other studies (Ciminale et al., 1997; Bai et al.,
2012).
HTLV-1 p30Tof and HTLV-2 p28 are important for viral prop-
agation in animal models (Silverman et al., 2004; Yamamoto et al.,
2008; Valeri et al., 2010). Both proteins sequester the tax/rex
mRNA in the nucleus, an effect that may result in reduced viral
expression and latency (Nicot et al., 2004; Younis et al., 2004).
p30Tof was also shown to interact with the RNA-binding domain
of Rex and thereby interfere with its binding to the RXRE (Sinha-
Datta et al., 2007; Bai et al., 2010) and to inhibit the expression
of Toll-like receptor 4 (Datta et al., 2006), suggesting a role in
the innate immune response. These two properties have not been
reported for p28. By interacting with the co-activator CBP/p300
(Zhang et al., 2000, 2001), p30Tof also affects Tax-mediated viral
expression and transcription of cellular genes involved in T-cell
activation and apoptosis (Michael et al., 2004; Taylor et al., 2009).
Interestingly, p28 does not appear to affect CBP/p300-mediated
transcription. Both p30Tof and p28 are targeted to the nucleus, but
only p30Tof shows evident accumulation in the nucleoli (Ciminale
et al., 1995; D’Agostino et al., 1997). Interestingly, HTLV-2 p28
and tRex are expressed at higher levels compared to their HTLV-1
counterparts p30/Tof and p21Rex, suggesting a higher propensity
of HTLV-2 for latency compared to HTLV-1 (Bender et al., 2012).
p13 corresponds to the C-terminal 87 amino acids of p30Tof
(Koralnik et al., 1992), and it is localized mainly in the mito-
chondrial inner membrane (Ciminale et al., 1999; D’Agostino
et al., 2002) and in part to the nucleus (Silic-Benussi et al.,
2010b; Andresen et al., 2011). Using a rabbit animal model,
Hiraragi et al. (2006) showed that p13 is required for viral
infectivity in vivo. p13 increases mitochondrial permeability
to K+ and activates the electron transport chain, resulting in
increased mitochondrial reactive oxygen species (ROS) produc-
tion (Silic-Benussi et al., 2009). While p13 has a mitogenic effect
in normal resting T cells, which have low ROS levels, the
protein induces death of transformed T-cells, which are character-
ized by a high ROS setpoint (Ciminale et al., 1999; D’Agostino
et al., 2005; Hiraragi et al., 2005; Silic-Benussi et al., 2004,
2010a,b). So far no HTLV-2 homologue of HTLV-1 p13 has been
identiﬁed.
HTLV-1 p12 and its HTLV-2 homologue p10 are coded by the
x-I ORF. p12 localizes in the endoplasmic reticulum (ER) and in
the Golgi apparatus, where it reduces the expression of the β and
γc chains of the interleukin-2 receptor (IL-2R, Mulloy et al., 1996)
and of MHC-I, thus hindering lysis of HTLV-1-infected cells by
CTL (Johnson et al., 2001). p12 also activates STAT-5, which pro-
vides a mitogenic signal to T cells (Nicot et al., 2001) and interacts
with calreticulin and calnexin (Ding et al., 2001), resulting in incre-
sased Ca2+ release from the ER (Ding et al., 2002) and activation
of NF-AT, a mitogenic pathway in T-cells (Albrecht et al., 2002;
Kim et al., 2003). Within the ER, p12 is cleaved into an 8-kDa
protein (p8) which trafﬁcks to the immunological synapse and
favours T-cell anergy. p8 also increases cell-to-cell viral transmis-
sion through the formation of intercellular conduits (Van Prooyen
et al., 2010a,b). In analogy to p12, HTLV-2 p10 was shown to bind
the MHC heavy chain; however, p10 does not bind the IL2R β
chain or the 16-kDa subunit of the vacuolar H+ ATPase (John-
son et al., 2000). No homologue of p8 has been described in
HTLV-2.
A recent study from Valeri et al. (2010), showed that p12 is
required for in vivo propagation in macaques but not in rabbits.
The x-V ORF of HTLV-2 codes for p11 from a doubly spliced
transcript that also codes for p10 (Ciminale et al., 1995). Aside
from its ability to bind to MHC heavy chain (Johnson et al., 2000),
nothing is known about the function of this protein. HTLV-1 also
possesses an x-V ORF, but it does not appear to produce a p11
homologue. The function of p11 is still unclear.
HBZ AND APH-2
The structure and function of HBZ and APH-2 were recently
reviewed (Barbeau et al., 2013). HBZ is a nuclear transcriptional
factor (Gaudray et al., 2002), able to interact with ATF/CREB
proteins through its basic zipper (bZIP) domain causing the
inhibition of its DNA-binding activity (Hivin et al., 2006); this
effect also inﬂuences the ability of Tax-1 to activate HTLV-1
transcription (Halin et al., 2009). APH-2 is likewise able to
inhibit Tax-2-mediated transcription but its repressive activity
is weaker than that of HBZ (Halin et al., 2009). This difference
may be ascribed to the presence in HBZ but not in APH-2,
of a transcriptional activation domain within its N-terminal
region that mediates its interaction with the KIX domain of
p300/CBP, thus competing for its binding to Tax-1 (Clerc et al.,
2008).
HBZ also deregulates several cellular pathways including c-Jun
and JunD, FoxP3, NF-κB, TGF-β and Wnt (Barbeau et al., 2013).
In addition, HBZ, may enhance its own expression by controlling
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the transcriptional activity of JunD (Gazon et al., 2012). Very little
is known about the regulation of APH-2 expression in infected
cells. However, unlike HBZ, APH-2 enhances the transcriptional
activity of c-Jun family proteins (Marban et al., 2012).
The role of HBZ in T-cell transformation is supported by the
ﬁnding that while Tax-1 expression is often repressed in ATL cells
and appears to be dispensable for the late stages of leukemogenesis,
HBZ is constitutively expressed in most ATL cases (Satou et al.,
2006). Transgenic mice expressing HBZ in CD4+ T cells develop
T-cell lymphomas and systemic inﬂammation that are reminiscent
of ATL and HAM/TSP (Satou et al., 2011).
Although HTLV-2 is not causally linked to leukemia or lym-
phoma, it has been associated with lymphocytosis in infected
patients (Bartman et al., 2008). This is consistent with the obser-
vation that APH-2 is detected in most PBMCs of HTLV-2-infected
patients (Halin et al., 2009) and that its expression is well corre-
lated to proviral DNA load (Douceron et al., 2012). Interestingly,
it was observed that the APH-2 mRNA, similarly to HBZ, accu-
mulates in the nucleus (Bender et al., 2012). Barbeau et al. (2013)
have recently proposed a model to explain the different effects
of HBZ and APH-2 on T-cell proliferation. Both HBZ and of
APH-2 can suppress Tax expression, thus favoring evasion of
the immune response. In addition, HBZ can stimulate its own
expression, inhibit Tax-1-dependent viral expression and induce
T-cell proliferation, which can lead to ATL. APH-2 is unable to
induce cell proliferation and only partially down-regulates Tax-2
expression.
Although dispensable for the HTLV-1 infection and immortal-
ization of T lymphocytes in vitro, studies conducted on a rabbit
animal model suggest that HBZ enhances HTLV-1infectivity and
persistence in vivo (Arnold et al., 2006). Furthermore, HBZ trans-
genic mice develop systemic inﬂammation and a CD4+ T-cell
neoplasm that is reminiscent of ATL (Satou et al., 2011). Inter-
estingly, in contrast to HBZ, HTLV-2 APH-2 appears to be
dispensable for viral infection and persistence in a rabbit ani-
mal model (Yin et al., 2012), suggesting a functional divergence
of the in vivo function of the HTLV-1 and HTLV-2 antisense
proteins.
TROPISM AND CLONALITY
The preferential cellular tropism of HTLV-1 for CD4+ T cells
and of HTLV-2 for CD8+ T cells is still not clearly understood.
It appears that the two viruses make different use of the hep-
aran sulfate proteoglycans to enter T cells (Jones et al., 2006),
although recent evidence obtained in vivo rabbit model indi-
cates that the apparent tropism for CD4+ or CD8+ cells mainly
reﬂects preferential clonal expansion of infected cells (Kannian
et al., 2012). Both HTLV-1 and HTLV-2 are capable of induc-
ing clonal expansion of infected cells in vivo (Wattel et al., 1995;
Cimarelli et al., 1996). A detailed analysis in asymptomatic car-
riers, TSP/HAM and ATLL patients revealed that the genomic
integration site and transcriptional orientation of the provirus are
important factors for determining clonal abundance in vivo (Gillet
et al., 2011).
A very recent study demonstrated that, contrary to previous
hypotheses, HTLV-2-infected individuals have a small number
of highly expanded CD8+ T-cell clones, suggesting that HTLV-2
may be subjected to a more strict clonal selection than HTLV-1 in
healthy carriers. These data suggest that selective clonal prolifera-
tion is more directly responsible for determining the viral burden
of HTLV-2 than it does for HTLV-1 (Melamed et al., 2014). In
contrast to observations made for HTLV-1, the environment sur-
rounding the integration sites does not seem to have a substantial
impact on the expansion of HTLV-2-infected clones (Melamed
et al., 2014).
The presence of few very abundant HTLV-2-infected clones
is apparently reminiscent of the proﬁle found in ATLL patients.
However, the fact that HTLV-2 is not causally linked to a
T-cell malignancy suggests that clonal abundance and hetero-
geneity may not per se constitute a determinant of malig-
nant transformation and clinical outcome of HTLV infection
(Melamed et al., 2014).
CONCLUSIONS
From the comparative analysis on the functional properties of
HTLV-1 and HTLV-2 reported above, the following major dif-
ferences can be outlined: (i) HTLV-2 is characterized by a more
abundant expression of gene products that may favor viral latency
(i.e., p28 and tRex); (ii) Tax-1 presents a PDZ binding motif,
which is absent from Tax-2 and allows interaction with host
factors regulating the cell cycle and proliferation; in addition,
Tax-2 is unable to activate the non-canonical NF-κB pathway;
(iii) Cis-acting inhibitory elements acting at the level of RNA
stability are present within HTLV-1 whereas they have not been
described in HTLV-2; (iv) while the truncated forms of Rex-2
were shown to inhibit Rex function, the HTLV-1 homologue
p21Rex might lack this activity; (v) HTLV-1 expresses p13 and p8,
which have not been described in HTLV-2; (vi) HTLV-2 expresses
p11, which does not seem to have a homologue in HTLV-1; (vii)
unlike APH-2, HBZ presents a basic zipper domain, as well a
transcriptional activation domain, which mediate its capacity to
enhance its own expression and deregulate several cellular path-
ways; (viii) HTLV-2 shows in vivo tropism for CD8+ T cells and
induces expansion of a relatively small number of highly abundant
clones.
In spite of the evidence accumulated so far on the similari-
ties and differences between HTLV-1 and HTLV-2, it is not yet
clear why only HTLV-1 causes a T-cell malignancy. While Tax-1
and HBZ induce T-cell lymphomas when expressed as trans-
genes in animal models, the in vivo transforming activities of
Tax-2 and APH-2 have not been investigated. Aside from the
NF-κB pathway, not much information is available regarding
the interactions of Tax-2 with cellular pathways known to be
engaged by Tax-1. The fact that HTLV-2, contrary to HTLV-1,
is characterized by an oligoclonal proliferative distribution in
asymptomatic hosts clearly indicates that the etiology of malig-
nant transformation by HTLV-1 cannot be uniquely attributed to
this phenomenon.
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